AI-Powered Clinical Trials: Building Health Equity through Technology with Dr. Harsha Rajasimha

In this episode, Dr. Harsha Rajasimha discusses his journey as a biotech entrepreneur and the founder of Jeeva Clinical Trials. He shares insights into the inefficiencies of traditional clinical trials and how AI can streamline the process, making it more efficient and accessible. The conversation also touches on the importance of inclusivity in clinical research, the role of AI agents, and the personal motivations behind his work. Dr. Rajasimha emphasizes the need for a unified platform to enhance collaboration and reduce complexity in clinical trials, ultimately aiming to improve patient outcomes.Chapters:00:00 Introduction to Jiva Clinical Trials and Harsha Rajaseema02:50 The Clinical Trial Process: Challenges and Innovations05:51 AI in Clinical Trials: Enhancing Efficiency and Security08:59 The Role of AI Agents in Clinical Research11:55 Addressing Inequities in Clinical Trials15:02 Philanthropy and Patient Advocacy in Rare Diseases18:08 The Journey of an Entrepreneur: Insights and AdviceGuest Information:Guest's Name: Dr. Harsha K. RajasimhaGuest's Title/Position: Founder & Chief Executive OfficerGuest's Linkedin: https://www.linkedin.com/in/harsharajasimha/Company / Affiliation: Jeeva Clinical Trials https://jeevatrials.com/Guest's Bio: Dr. Harsha K. Rajasimha is a scientist, entrepreneur, and patient advocate, and the Founder & CEO of Jeeva Clinical Trials—an AI-driven platform making clinical research more efficient and accessible worldwide. He also serves as Founder and Chair of the Indo US Organization for Rare Diseases, building global collaboration to improve outcomes for patients with rare conditions. Motivated by personal loss, Harsha has dedicated his 20-year career in precision medicine and biotech to advancing rare disease research, patient advocacy, and the use of technology to accelerate clinical trials.Takeaways:Dr. Harsha Rajasimha is the founder of Jeeva Clinical Trials.Clinical trials typically take 8-10 years to complete.AI can significantly reduce the time and cost of clinical trials.The current clinical trial infrastructure is complex and fragmented.Jeeva aims to unify the clinical trial process with a single platform.AI agents will automate repetitive tasks in clinical trials.Inclusivity in clinical trials is crucial for diverse patient representation.Philanthropy plays a key role in Dr. Rajasimha's mission.The platform supports over 100 languages for global accessibility.Community support is essential for entrepreneurial success.